#non-Hodgkin's lymphoma

CAR-T Therapy: Lifeline to A Cure?

Zynlonta led to complete remission in nearly a quarter of patients with large B-cell lymphoma.

After a median follow-up of 13 months, four of the five patients had ongoing complete remission.

After approval of the latest cellular therapy for non-Hodgkin lymphoma, the big challenge is how to extend it to common solid tumors.

Half of patients treated with Breyanzi experienced complete remission, and a majority of these responses were durable.

Here’s a list of the approved drugs to treat lyphoma including Non-Hodgkin lymphoma and Hodgkin lymphoma. Click on any of the medicat...

A former labor and delivery nurse, Lindy Sledge, 62, lives with her family in Franklin, Kentucky. She has mantle cell lymphoma.

Yescarta led to complete remission in people with advanced non-Hodgkin lymphoma.

A dedicated student of jiujitsu, Avie Barron, 36, was diagnosed with non-Hodgkin lymphoma in her right lung.

Lymphoma is a cancer that begins in the cells of the lymph system.

World Lymphoma Awareness Day (WLAD) is held on September 15 every year and is a day dedicated to raising awareness of lymphoma.

More than a third of people treated with Monjuvi plus Revlimid experienced complete remission.

Tecartus led to durable remission in a majority of participants in a Phase II study.

The popular weed killer has been linked to tens of thousands of cases of non–Hodgkin lymphoma.